<DOC>
	<DOCNO>NCT00051948</DOCNO>
	<brief_summary>This dose-ranging , open label , Phase 1-2a study TLK286 combination Paraplatin ( carboplatin ) patient recurrent ovarian cancer .</brief_summary>
	<brief_title>TLK286 Combination With Paraplatin ( Carboplatin ) Recurrent Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Inclusion Criteria Histologically cytologically confirm diagnosis epithelial cancer ovary , fallopian tube , primary peritoneal cancer Recurrent ovarian cancer persistent disease follow primary treatment At least one , four , prior chemotherapy regimen ( platinumcontaining count one ) At least 18 year age Exclusion Criteria Pregnant lactate woman History prior malignancy except adequately treat carcinoma situ uterine cervix , basal cell squamous cell skin cancer , cancer patient diseasefree least 2 year Known leptomeningeal metastasis carcinomatous meningitis Having receive whole pelvis radiation therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>